HHS Recommends Reclassification of Marijuana to Lower-Risk Drug Category
Medically reviewed by Drugs.com.
By Physician’s Briefing Staff HealthDay Reporter
THURSDAY, Aug. 31, 2023 -- The U.S. Department of Health and Human Services has asked the U.S. Drug Enforcement Agency to reclassify marijuana as a less dangerous drug under the Controlled Substances Act, a move that could potentially expand acceptance of the drug.
The DEA confirmed receiving an Aug. 29 letter requesting the change and will begin its own review, a spokesperson told Bloomberg News. The move would not legalize marijuana, but could move it from its Schedule I classification to a Schedule III. Schedule I drugs, which carry a high risk for abuse, include LSD, ecstasy, and heroin. Meanwhile, Schedule III drugs can be obtained with a prescription.
Last October, President Joe Biden announced initiatives to ease marijuana penalties. He pardoned all prior simple possession offenses charged federally, asking states to do the same. At that time, Biden also asked the HHS and U.S. Attorney General to review marijuana scheduling, its medical use, potential for abuse and dependence, and safety.
Cannabis advocates have said that rescheduling the drug would be acknowledging marijuana's legitimate uses, Bloomberg News reported. About 18 percent of Americans used cannabis at least once in 2019, according to data from the U.S. Centers for Disease Control and Prevention. The HHS recommendation comes after a U.S. Food and Drug Administration review that considered eight factors when determining whether a reclassification was warranted, Assistant Secretary for Health Rachel Levine, M.D., told Bloomberg News. Levine added that the National Institute on Drug Abuse agreed with the FDA recommendation.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Slight Decline Seen in U.S. Drug Overdose Deaths
THURSDAY, May 16, 2024 -- New 2023 provisional data from the National Center for Health Statistics show the first decline in deaths from drug overdose in the United States since...
American Psychiatric Association, May 4-8
The annual meeting of the American Psychiatric Association was held from May 4 to 8 in New York City, drawing participants from around the world, including clinicians...
Number, Size of Seizures of Fentanyl Increasing in the United States
MONDAY, May 13, 2024 -- The number and size of seizures of fentanyl are increasing in the United States, with most seizures occurring in the West, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.